Elutia (ELUT) Cash from Investing Activities (QoQ) (2020 - 2026)
Powered by 
Analysis
Elutia (ELUT) Cash from Investing Activities (QoQ) (2020 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.79 Bn | 175.19 Bn | 7.27 Bn |
| 2 | Intuitive Surgical | 127.05 Bn | 121.83 Bn | 1.96 Bn |
| 3 | Medtronic | 117.00 Bn | 108.18 Bn | 6.34 Bn |
| 4 | Stryker | 103.78 Bn | 100.31 Bn | 4.50 Bn |
| 5 | Boston Scientific | 63.50 Bn | 62.96 Bn | 3.85 Bn |
| 6 | Edwards Lifesciences | 49.72 Bn | 45.46 Bn | 1.35 Bn |
| 7 | Alcon | 32.98 Bn | 31.52 Bn | 1.68 Bn |
| 8 | Dexcom | 32.05 Bn | 30.10 Bn | 830.00 Mn |
| 9 | Steris | 20.68 Bn | 20.19 Bn | 684.20 Mn |
| 10 | Elutia | 36.01 Mn | 16.11 Mn | 1.45 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -167.65% |
| Mar 31, 2026 | -100.04% |
| Dec 31, 2025 | 12,731.90% |
| Sep 30, 2025 | -452.63% |
| Jun 30, 2025 | 58.99% |
| Mar 31, 2025 | -195.74% |
| Dec 31, 2024 | 82.82% |
| Sep 30, 2024 | -400.55% |
| Jun 30, 2024 | 1,313.33% |
| Mar 31, 2024 | -100.10% |
| Dec 31, 2023 | 23,546.77% |
| Sep 30, 2023 | 27.06% |
| Jun 30, 2023 | 53.30% |
| Mar 31, 2023 | -35.82% |
| Dec 31, 2022 | -14.53% |
| Sep 30, 2022 | 54.12% |
| Jun 30, 2022 | -650.00% |
| Mar 31, 2022 | -36.00% |
| Dec 31, 2021 | 74.23% |
| Sep 30, 2021 | 16.38% |